PainCeptor Pharma Inc., a Montreal-based drug company focused on the treatment of chronic and acute pain, has raised Cdn$24.4 million in Series B funding. Participants included Desjardins Venture Capital, CDP Capital (managed by VantagePoint Venture Partners), T2C2/Bio 2000, Business Development Bank of
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.